IBB vs VEA
iShares Biotechnology ETF vs Vanguard FTSE Developed Markets ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
VEA—
Vanguard FTSE Developed Markets ETF
Developed-market stocks outside the US and Canada.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | VEA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
Holdings data unavailable for IBB.
VEA top holdings
Holdings data unavailable for VEA.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About VEA
VEA (Vanguard FTSE Developed Markets ETF) is Developed-market stocks outside the US and Canada.